Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
15,753,386
-
Shares change
-
-1,939,558
-
Total reported value, excl. options
-
$108,985,984
-
Value change
-
-$42,814,279
-
Number of buys
-
31
-
Number of sells
-
-45
-
Price
-
$6.92
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2016
92 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q4 2016.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,753,386 shares
of 385,837,333 outstanding shares and own 4.08% of the company stock.
Largest 10 shareholders include Paradice Investment Management LLC (1,626,496 shares), HEARTLAND ADVISORS INC (1,533,750 shares), Boston Partners (1,501,750 shares), JANUS CAPITAL MANAGEMENT LLC (1,420,529 shares), Lapides Asset Management, LLC (1,168,800 shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (883,571 shares), STONEHILL CAPITAL MANAGEMENT LLC (738,829 shares), 22NW, LP (720,154 shares), MILLENNIUM MANAGEMENT LLC (573,300 shares), and Senvest Management, LLC (461,584 shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.